UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer

The New England journal of medicine, 2017-08, Vol.377 (6), p.513-522

2017

Volltextzugriff (PDF)

Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective

Journal of clinical oncology, 2015-10, Vol.33 (29), p.3356-3364

2015

Volltextzugriff (PDF)

Long-term Outcomes of Bevacizumab and Chemoradiation for Locoregionally Advanced Nasopharyngeal Carcinoma: A Nonrandomized Controlled Trial

JAMA network open, 2023-06, Vol.6 (6), p.e2316094

2023

Volltextzugriff (PDF)

Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)

Journal of clinical oncology, 2018-05, Vol.36 (14), p.1412-1418

2018

Volltextzugriff (PDF)

Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial

Journal of clinical oncology, 2018-11, Vol.36 (31), p.JCO2018777847-3100

2018

Volltextzugriff (PDF)

What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis

Journal of clinical oncology, 2017-02, Vol.35 (5), p.498-505

2017

Volltextzugriff (PDF)

Analysis of Hepatocellular Carcinoma Stereotactic Body Radiation Therapy Dose Prescription Method Using Uncomplicated Tumor Control Probability Model

Advances in radiation oncology, 2021-09, Vol.6 (5), p.100739-100739, Article 100739

2021

Volltextzugriff (PDF)

Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials

Clinical cancer research, 2018-04, Vol.24 (8), p.1824-1833

2018

Volltextzugriff (PDF)

Epigenetic Therapy Using Belinostat for Patients With Unresectable Hepatocellular Carcinoma: A Multicenter Phase I/II Study With Biomarker and Pharmacokinetic Analysis of Tumors From Patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group

Journal of clinical oncology, 2012-09, Vol.30 (27), p.3361-3367

2012

Volltextzugriff (PDF)

Phase I Trial of Recombinant Modified Vaccinia Ankara Encoding Epstein―Barr Viral Tumor Antigens in Nasopharyngeal Carcinoma Patients

Cancer research (Chicago, Ill.), 2013-03, Vol.73 (6), p.1676-1688

2013

Volltextzugriff (PDF)

Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments

Expert reviews in molecular medicine, 2007-05, Vol.9 (12), p.1-24

2007

Volltextzugriff (PDF)

Systematic evaluation of circulating inflammatory markers for hepatocellular carcinoma

Liver international, 2017-02, Vol.37 (2), p.280-289

2017

Volltextzugriff (PDF)

The emerging data on choice of optimal therapy for locally advanced nasopharyngeal carcinoma

Current opinion in oncology, 2020-05, Vol.32 (3), p.187-195

2020

Volltextzugriff (PDF)

Plasma Epstein-Barr Viral Deoxyribonucleic Acid Quantitation Complements Tumor-Node-Metastasis Staging Prognostication in Nasopharyngeal Carcinoma

Journal of clinical oncology, 2006-12, Vol.24 (34), p.5414-5418

2006

Volltextzugriff (PDF)

Prospective Randomized Study of Intensity-Modulated Radiotherapy on Salivary Gland Function in Early-Stage Nasopharyngeal Carcinoma Patients

Journal of clinical oncology, 2007-11, Vol.25 (31), p.4873-4879

2007

Volltextzugriff (PDF)

Current treatment of nasopharyngeal carcinoma

European journal of cancer (1990), 2011-09, Vol.47, p.S302-S303

Chan, Anthony T.C

2011

Volltextzugriff (PDF)

New Utility of an Old Marker: Serial α-Fetoprotein Measurement in Predicting Radiologic Response and Survival of Patients With Hepatocellular Carcinoma Undergoing Systemic Chemotherapy

Journal of clinical oncology, 2009-01, Vol.27 (3), p.446-452

2009

Volltextzugriff (PDF)

Prognostic significance of the total dose of cisplatin administered during concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma

Radiotherapy and oncology, 2012-09, Vol.104 (3), p.300-304

2012

Volltextzugriff (PDF)

Sequencing Analysis of Plasma Epstein-Barr Virus DNA Reveals Nasopharyngeal Carcinoma-Associated Single Nucleotide Variant Profiles

Clinical chemistry (Baltimore, Md.), 2020-04, Vol.66 (4), p.598-605

2020

Volltextzugriff (PDF)

Preclinical evaluation of the VEGF/Ang2 bispecific nanobody BI 836880 in nasopharyngeal carcinoma models

Investigational new drugs, 2023-10, Vol.41 (5), p.699-709

2023

Volltextzugriff (PDF)

WNT5A Exhibits Tumor-Suppressive Activity through Antagonizing the Wnt/β-Catenin Signaling, and Is Frequently Methylated in Colorectal Cancer

Clinical cancer research, 2008-01, Vol.14 (1), p.55-61

2008

Volltextzugriff (PDF)

Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta-analysis of eight randomized trials and 1753 patients

International journal of radiation oncology, biology, physics, 2006, Vol.64 (1), p.47-56

2006

Volltextzugriff (PDF)

Shift detection discrepancy between ExacTrac Dynamic system and cone‐beam computed tomography

Journal of applied clinical medical physics, 2022-05, Vol.23 (5), p.e13567-n/a

2022

Volltextzugriff (PDF)

Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: Current and future directions

Cancer science, 2008-07, Vol.99 (7), p.1311-1318

2008

Volltextzugriff (PDF)

The metalloprotease ADAMTS8 displays antitumor properties through antagonizing EGFR-MEK-ERK signaling and is silenced in carcinomas by CpG methylation

Molecular cancer research, 2014-02, Vol.12 (2), p.228-238

2014

Volltextzugriff (PDF)

1 – 25 von 288

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(278)
Mit Volltextzugriff
(267)

Publikationsform

Sprache

Englisch
(288)

Erscheinungsjahr

n.n

Thema

Science & Technology
(243)
Life Sciences & Biomedicine
(232)
Humans
(213)
Oncology
(151)
Female
(108)
Male
(106)
Biological And Medical Sciences
(96)
Middle Aged
(95)
Medical Sciences
(94)
Adult
(87)
Tumors
(87)
Nasopharyngeal Carcinoma
(81)
Aged
(70)
Nasopharyngeal Neoplasms - Pathology
(55)
Chemotherapy
(43)
Epstein-Barr Virus
(42)
Prognosis
(41)
Neoplasm Staging
(39)
Otorhinolaryngology. Stomatology
(39)
Cell Line, Tumor
(38)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer

Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective

Long-term Outcomes of Bevacizumab and Chemoradiation for Locoregionally Advanced Nasopharyngeal Carcinoma: A Nonrandomized Controlled Trial

Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)

Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial

What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis

Analysis of Hepatocellular Carcinoma Stereotactic Body Radiation Therapy Dose Prescription Method Using Uncomplicated Tumor Control Probability Model

Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials

Epigenetic Therapy Using Belinostat for Patients With Unresectable Hepatocellular Carcinoma: A Multicenter Phase I/II Study With Biomarker and Pharmacokinetic Analysis of Tumors From Patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group

Phase I Trial of Recombinant Modified Vaccinia Ankara Encoding Epstein―Barr Viral Tumor Antigens in Nasopharyngeal Carcinoma Patients

Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments

Systematic evaluation of circulating inflammatory markers for hepatocellular carcinoma

The emerging data on choice of optimal therapy for locally advanced nasopharyngeal carcinoma

Plasma Epstein-Barr Viral Deoxyribonucleic Acid Quantitation Complements Tumor-Node-Metastasis Staging Prognostication in Nasopharyngeal Carcinoma

Prospective Randomized Study of Intensity-Modulated Radiotherapy on Salivary Gland Function in Early-Stage Nasopharyngeal Carcinoma Patients

Current treatment of nasopharyngeal carcinoma

New Utility of an Old Marker: Serial α-Fetoprotein Measurement in Predicting Radiologic Response and Survival of Patients With Hepatocellular Carcinoma Undergoing Systemic Chemotherapy

Prognostic significance of the total dose of cisplatin administered during concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma

Sequencing Analysis of Plasma Epstein-Barr Virus DNA Reveals Nasopharyngeal Carcinoma-Associated Single Nucleotide Variant Profiles

Preclinical evaluation of the VEGF/Ang2 bispecific nanobody BI 836880 in nasopharyngeal carcinoma models

WNT5A Exhibits Tumor-Suppressive Activity through Antagonizing the Wnt/β-Catenin Signaling, and Is Frequently Methylated in Colorectal Cancer

Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta-analysis of eight randomized trials and 1753 patients

Shift detection discrepancy between ExacTrac Dynamic system and cone‐beam computed tomography

Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: Current and future directions

The metalloprotease ADAMTS8 displays antitumor properties through antagonizing EGFR-MEK-ERK signaling and is silenced in carcinomas by CpG methylation

Suchergebnisse filtern